Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use

Biol Psychiatry. 1997 Jul 15;42(2):144-6. doi: 10.1016/S0006-3223(97)00248-5.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antidepressive Agents, Second-Generation / administration & dosage
  • Antidepressive Agents, Second-Generation / adverse effects*
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Bipolar Disorder / drug therapy*
  • Bipolar Disorder / psychology
  • Clozapine / adverse effects
  • Clozapine / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Dyskinesia, Drug-Induced / diagnosis
  • Dyskinesia, Drug-Induced / drug therapy*
  • Female
  • Humans
  • Neurologic Examination / drug effects
  • Paroxetine / administration & dosage
  • Paroxetine / adverse effects*
  • Serotonin Receptor Agonists / administration & dosage
  • Serotonin Receptor Agonists / adverse effects*
  • Sumatriptan / administration & dosage
  • Sumatriptan / adverse effects*

Substances

  • Antidepressive Agents, Second-Generation
  • Antipsychotic Agents
  • Serotonin Receptor Agonists
  • Paroxetine
  • Sumatriptan
  • Clozapine